BMGL (Basel Medical Group) Buyback Yield %: 0.00 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BMGL Basel Medical Group Ltd BMGL
17 GF Score
Price $5.70
! 3 Warning Signs
View Full Analysis

What is Basel Medical Group Buyback Yield %?

Basel Medical Group BMGL -7.17% 17 Buyback Yield % is 0.00 as of Jul. 16, 2026. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 273 Healthcare Providers & Services companies, Basel Medical Group ranks worse than 366300% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Basel Medical Group's current buyback yield was 0.00%.

Basel Medical Group Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Basel Medical Group's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basel Medical Group Buyback Yield % Chart

Basel Medical Group Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Buyback Yield %
0.00 0.00 0.00 -17.89

Basel Medical Group Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 -17.89 0.00

BMGL vs AMS, HLYK, BICX: Buyback Yield % Comparison

For the Medical Care Facilities subindustry, Basel Medical Group's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Basel Medical Group Buyback Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Basel Medical Group's Buyback Yield % falls into.


BMGL
17GF Score
Basel Medical Group Ltd BMGL
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Basel Medical Group Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Basel Medical Group's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5.979) / 33.4284
=-17.89%

Basel Medical Group's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 9.2022
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Basel Medical Group (BMGL) has a Buyback Yield % of 0.00 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Basel Medical Group and its competitors. According to the industry distribution chart, Basel Medical Group ranks #999999 out of 273 companies in the Healthcare Providers & Services industry.
Is Basel Medical Group's Buyback Yield % too high?
Basel Medical Group's current Buyback Yield % is 0.00. Based on the distribution chart, Basel Medical Group ranks #999999 out of 273 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Buyback Yield % compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #999999 out of 273 companies for Buyback Yield %. This places Basel Medical Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Basel Medical Group and its competitors. Basel Medical Group's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Buyback Yield % is 0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Basel Medical Group Business Description

Address 6 Napier Road, Unit No. 02-10/11, Gleneagles Medical Centre, Singapore, SGP, 258499
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score

Get the complete analysis for BMGL

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.70
Price